FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • FAQ
  • How to use FRC

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Medline Inc. Stock AnalysisComprehensive stock analysis for Medline Inc. (MDLN) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisMDLN
MDLN
Medline Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
MDLN
Home🔹Stocks🔹Medline Inc.

Medline Inc.

🇺🇸MDLN•NASDAQ

Medline Inc.

🇺🇸MDLN•NASDAQ
Market cap
$27.51B
Sentiment

Your view on MDLN

Mkt Cap
$27.51B
Sentiment
Your view
MDLN
Medline Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
MDLN
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Medline Inc.

Industry
Medical - Instruments & Supplies
Sector
Healthcare
CEO
James Boyle
Headquarters
US
Industry
Medical - Instruments & Supplies
Sector
Healthcare
CEO
James Boyle
Headquarters
US
Description

Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions.

The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and laboratory and diagnostics.

Its front line care offers med-surg products for patient-facing needs, including wound care products, exam gloves, skin care and incontinence products, environment cleaning supplies, textiles, hand sanitizer, durable medical equipment, patient plastics, and decolonization and infection control products.

Its surgical solutions provide operating room and perioperative environment product solutions, including surgical procedure trays, drapes and gowns, personal protective equipment, sterile wraps, surgical instruments, surgeon's gloves, procedure kits, and orthopedic implants.

Its laboratory and diagnostics offer laboratory and diagnostic product solutions, including point of care testing, analyzers and instrumentation, lab and diagnostic consumables, diagnostic instruments, vital signs monitors, and anatomic pathology and phlebotomy products. It provides its products to domestic and international consumers.

The Supply Chain Solutions segment procures and distributes a variety of third-party products from national brands. It provides logistics and supply chain optimization services to domestic and international consumers.

It also provides supply chain optimization services such as, consulting engagements, outsourced warehouse and technology management, put-away-ready packaging, third-party logistics, inventory rationalization, and route planning. Medline Inc. was founded in 1966 and is based in Northfield, Illinois.

FRC Research

Media

Infographics, videos, and posts covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks it is worth vs. the current price.

FRC's fair value estimate for Medline Inc., and the rating behind it. MDLN last traded at $32.53, 37.8× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Valuation, profitability, liquidity and leverage ratios for Medline Inc.. Starting points for Medline Inc.: P/E 37.8, EPS $0.81, beta -0.41 — an Medical - Instruments & Supplies name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Dividend history, yield and payout sustainability for Medline Inc.. Medline Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Reported vs. expected earnings history for Medline Inc.. Trailing twelve-month EPS for Medline Inc. stands at $0.81. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Income statement, balance sheet and cash flow history for Medline Inc.. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Medline Inc. valued side by side against its closest peers. Medline Inc. is measured against Medical - Instruments & Supplies peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Ownership & News

Institutional Ownership

Premium

Which funds and firms own the stock.

Which institutions hold Medline Inc., and how their positions are changing. At a $27.51B market value, institutional positions materially move Medline Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.

Insider Trading

Premium

Recent buying and selling by company executives.

Buying and selling by Medline Inc. executives and directors. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.

Senate Trading

Premium

U.S. Senator disclosures filed under the STOCK Act.

U.S. Senate disclosures naming Medline Inc.. Medline Inc. is a $27.51B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.

House Trading

Premium

U.S. Representative disclosures filed under the STOCK Act.

U.S. House of Representatives disclosures naming Medline Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.

News

Latest headlines and market coverage.

Latest headlines and company announcements for Medline Inc.. Coverage tracks Medline Inc. within Medical - Instruments & Supplies (Healthcare). Press releases and market coverage, newest first.

Peer companies

  • AVTR — Avantor, Inc.
  • BLCO — Bausch + Lomb Corporation
  • BRCB — Black Rock Coffee Bar, Inc. Class A Common Stock
  • COO — The Cooper Companies, Inc.
  • INFU — InfuSystem Holdings, Inc.
  • KMTS — KESTRA MEDICAL TECHNOLOGIES, LTD.
  • LMAT — LeMaitre Vascular, Inc.
  • LMRI — Lumexa Imaging Holdings, Inc. Common Stock

More Medical - Instruments & Supplies companies

  • EKTAF — Elekta AB (publ)
  • EKTAY — Elekta AB (publ)
  • EMBC — Embecta Corp.
  • ESLOF — EssilorLuxottica S.A.
  • ESLOY — EssilorLuxottica S.A.
  • FEMY — Femasys Inc.
  • FPH.AX — Fisher & Paykel Healthcare Corporation Limited
  • FSPKF — Fisher & Paykel Healthcare Corporation Limited
  • GRRMF — Gerresheimer AG
  • HBIO — Harvard Bioscience, Inc.
  • HOCPF — HOYA Corporation
  • HOCPY — HOYA Corporation

ETFs holding Medline Inc.

  • IPO — Renaissance IPO ETF (4.76%)
  • FPX — First Trust US Equity Opportunities ETF (2.35%)
  • FXH — First Trust Health Care AlphaDEX Fund (1.83%)
  • FHH.TO — First Trust AlphaDEX U.S. Health Care Sector Index ETF (1.83%)
  • BGUS — Baillie Gifford U.S. Equity Growth ETF (1.74%)
  • QQQJ — Invesco NASDAQ Next Gen 100 ETF (1.40%)
  • XHE — State Street SPDR S&P Health Care Equipment ETF (1.38%)

News

Latest Market News